Currently available data about IL-27 highlight that this is another cytokine owing an anti-inflammatory activity and therefore the identification of molecules acting as IL-27 agonists may represent an intriguing option to be explored in RA. This evidence concerns the gene IL27 and rheumatoid arthritis.